New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-1)

Sum=130

Publishing Process of This Article

Item

Count

Browse

Download

Sum=3

Dec 24, 2024 (publication date) through Oct 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Oncol. Dec 24, 2024; 15(12): 1491-1500
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1491

Table 1 Cost-effectiveness analysis of human papillomavirus screening of Changsha city from 2019-2022

Total cost	Screening population	Per capita cost	Number of early diagnoses	4 years per capita GDP	The average cost of detecting early cases	EDCI
62812440	523437	120 RMB	5915	127850	10619	0.083

EDCI: Early detection cost coefficient.

Citation: Zu YE, Wang SF, Peng XX, Wen YC, Shen XX, Wang XL, Liao WB, Jia D, Liu JY, Peng XW. New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial. World J Clin Oncol 2024; 15(12): 1491-1500
URL: https://www.wjgnet.com/2218-4333/full/v15/i12/1491.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i12.1491